Publicacions (177) Publicacions de MARIA JESUS SANZ FERRANDO Mostra dades de recerca referenciades.

filter_list

2025

  1. CXCL16/CXCR6 axis arises as a potential peripheral biomarker of early COPD development – results from a pilot study

    Frontiers in Medicine, Vol. 12

  2. Historia y fármacos antihistáminicos

    Velázquez, farmacología básica y clínica (Editorial Médica Panamericana), pp. 507-524

2022

  1. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?

    Biology, Vol. 11, Núm. 8

  2. Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity

    Microvascular Research, Vol. 139

  3. Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players

    Biomedicine and Pharmacotherapy, Vol. 145

  4. Effect of personality on blood glucose control in patients with type 1 diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 677-685

  5. Erratum: L-selectin regulates human neutrophil transendothelial migration (J. Cell Sci. (2021) 134 (jcs250340) DOI: 10.1242/jcs.250340)

    Journal of Cell Science

  6. Revealing 2-dimethylhydrazino-2-alkyl alkynyl sphingosine derivatives as sphingosine kinase 2 inhibitors: Some hints on the structural basis for selective inhibition

    Bioorganic Chemistry, Vol. 121

  7. Synthesis and biological studies of “Polycerasoidol” and “trans-δ-Tocotrienolic acid” derivatives as PPARα and/or PPARγ agonists

    Bioorganic and Medicinal Chemistry, Vol. 53

  8. The radiographic assessment of lung edema score of lung edema severity correlates with inflammatory parameters in patients with coronavirus disease 2019—Potential new admission biomarkers to predict coronavirus disease 2019 worsening

    Frontiers in Medicine, Vol. 9

  9. Veinte Años de AFT

    Actualidad en farmacología y terapéutica, Vol. 20, Núm. 3, pp. 201-202